 JPMorgan Chase Co. boosted its stake in Flexion Therapeutics Inc NASDAQ:FLXN by 18.1 during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 174,912 shares of the specialty pharmaceutical companys stock after buying an additional 26,763 shares during the quarter. JPMorgan Chase Co. ... 